Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Amarin Corp Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Amarin and HLS Therapeutics Enter into Agreement 11
Amarin Enters into Development Agreement with Eddingpharm 12
Amarin And Kowa Pharm Enter Into Co-Promotion Agreement For Vascepa Capsules 13
Licensing Agreements 15
Amarin Enters into Licensing Agreement with Mochida Pharma 15
Equity Offering 16
Amarin Raises USD65 Million in Public Offering of American Depositary Shares 16
Amarin Files Registration Statement for Public Offering of ADS 17
Amarin Announces Underwriter’s Exercise of Over-Allotment Option of Public Offering of ADS for USD69 Million 18
Amarin to Raise USD53 Million in Private Placement of American Depositary Shares 20
Amarin Completes Public Offering Of Shares For US$121.5 Million 21
Debt Offering 23
Corsicanto II Designated Activity (Amarin) Raises USD30 Million in Exchangeable Senior Notes 23
Amarin to Raise USD31.3 Million in Private Placement of 3.5% Notes Due 2032 24
Amarin Corporation Completes Private Placement For US$100 Million 25
Amarin Completes Private Placement Of 3.5% Exchangeable Senior Notes Due 2032 For US$150 Million 26
Acquisition 27
Teva Pharma Rumored To Acquire Amarin 27
Amarin Corp Plc – Key Competitors 28
Amarin Corp Plc – Key Employees 29
Amarin Corp Plc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Nov 01, 2018: Amarin reports third quarter 2018 financial results and provides update on operations 31
Aug 01, 2018: Amarin reports second quarter 2018 financial results and provides update on operations 35
May 02, 2018: Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations 38
Feb 27, 2018: Amarin Reports Announces Fourth Quarter and Full Year 2017 Financial Results 40
Nov 01, 2017: Amarin Reports Third Quarter 2017 Financial Results and Provides Update on Operations 45
Aug 02, 2017: Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations 47
May 03, 2017: Amarin reports lower Q1 net loss, re-affirms annual guidance 50
Feb 28, 2017: Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations 51
Jan 05, 2017: Amarin announces revenue forecast for 2017 54
Jan 05, 2017: Amarin Provides Preliminary 2016 Results and 2017 Outlook 56
Corporate Communications 58
Apr 23, 2018: Amarin Announces Promotes Aaron Berg To Chief Commercial Officer 58
Product News 59
06/12/2017: Vascepa (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides 59
05/18/2017: Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care 60
05/03/2017: Amarin Reports First Quarter 2017 Financial Results and Provides Update on Operations 61
03/16/2017: Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study 66
03/15/2017: Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology 67
01/05/2017: Amarin Provides Preliminary 2016 Results and 2017 Outlook 68
Clinical Trials 70
Sep 13, 2017: Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer 70
Aug 14, 2017: Amarin Provides Update on Vascepa 71
Other Significant Developments 73
Apr 04, 2018: Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa Promotion Initiatives 73
Appendix 75
Methodology 75
About GlobalData 75
Contact Us 75
Disclaimer 75
Amarin Corp Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Amarin Corp Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Amarin Corp Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amarin and HLS Therapeutics Enter into Agreement 11
Amarin Enters into Development Agreement with Eddingpharm 12
Amarin And Kowa Pharm Enter Into Co-Promotion Agreement For Vascepa Capsules 13
Amarin Enters into Licensing Agreement with Mochida Pharma 15
Amarin Raises USD65 Million in Public Offering of American Depositary Shares 16
Amarin Files Registration Statement for Public Offering of ADS 17
Amarin Announces Underwriter’s Exercise of Over-Allotment Option of Public Offering of ADS for USD69 Million 18
Amarin to Raise USD53 Million in Private Placement of American Depositary Shares 20
Amarin Completes Public Offering Of Shares For US$121.5 Million 21
Corsicanto II Designated Activity (Amarin) Raises USD30 Million in Exchangeable Senior Notes 23
Amarin to Raise USD31.3 Million in Private Placement of 3.5% Notes Due 2032 24
Amarin Corporation Completes Private Placement For US$100 Million 25
Amarin Completes Private Placement Of 3.5% Exchangeable Senior Notes Due 2032 For US$150 Million 26
Teva Pharma Rumored To Acquire Amarin 27
Amarin Corp Plc, Key Competitors 28
Amarin Corp Plc, Key Employees 29
Amarin Corp Plc, Subsidiaries 30
List of Figures
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9